Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Avivagen Inc VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


GREY:VIVXF - Post by User

Post by StoneMan45on Feb 17, 2021 10:25am
133 Views
Post# 32583887

just waiting on China....

just waiting on China....https://obj.ca/article/techopia/ottawa-bioscience-firm-avivagen-set-unveil-immune-boosting-supplements-humans?fbclid=IwAR1ON6rXdTO0z5VQQkqEydVJsLoIFuoIfYd3IrSql3xVLuLyKI760fy4Rk8

The product is now approved for use in animals in Brazil, Malaysia, Mexico, the Philippines, Taiwan, Thailand and the U.S. China is expected to give OxC-beta the green light shortly, opening up another massive market for Avivagen. 

“Where we are approved today, we’re making real traction,” Anthony says, adding the company expects to see “a pretty significant and dramatic increase in overall orders” in the next 12 months.

<< Previous
Bullboard Posts
Next >>